Medical/Pharmaceuticals

Ally Bridge Group Leads Pulmonx's $65 Million Financing, Further Strengthening Its Global Medtech Franchise

HONG KONG, May 10, 2019 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, announced today that it led an over-subscribed$65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its key p...

2019-05-10 10:05 3094

MLP Care's Strong Start to the First Quarter of 2019

ISTANBUL, May 10, 2019 /PRNewswire/ -- * In the first quarter of 2019, MLP Care's revenue (BIST: MPARK) increased to TL933 million, up by 25%. When revenues of managed hospitals are included, revenue growth in Q1 2019 is at 28% * Adj. EBITDA increased by 20%, bringing EBITDA margin to 18.0%....

2019-05-10 09:00 3090

Varex To Highlight Advanced Imaging Components At China International Medical Equipment Fair In Shanghai

Varex To Launch 'Local for Local' Campaign At CMEF Varex at CMEF 2019: Booth #1D11 May 14-17, 2019 Conference & Exhibit: China International Medical Equipment Fair National Convention & Exhibition Center, Shanghai, China SALT LAKE CITY, May 9, 2019 /PRNewswire/ -- Varex Imaging Corporation (Na...

2019-05-09 20:30 2807

CloudMinds Partners with Retail Pharmacy Giant in U.S., Introducing Powerful Cloud AI Solution for Healthcare

BEIJING, May 9, 2019 /PRNewswire/ -- Artificial intelligence (AI) is pioneering a new wave of innovation in the medical industry prompting large healthcare providers to quickly implement AI to adapt to this technological revolution. AI has become a key strategic focal point for retail pharmacies,...

2019-05-09 16:47 2256

People with lupus feel the disease greatly affects their emotional and mental well-being

World Lupus Federation global survey highlights the need for education, specialty care and emotional support for millions of people living with lupus WASHINGTON, May 9, 2019 /PRNewswire/ -- More than 6 in 10 (61.6%) people living with lupus say the disease has had 'a lot' of effect on their emoti...

2019-05-09 12:01 928

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

REHOVOT, Israel, May 9, 2019 /PRNewswire/ -- Pi-Cardia Ltd. (www.pi-cardia.net ), announced today that it successfully completed the First-in-Human (FIH) studies with its Leaflex™ Performer catheter. The Leaflex™ Performer is a trans-femoral catheter that uses two unique...

2019-05-09 09:00 1912

Vietnam's "K Hospital" Uses Elekta Solutions to Make Precision Radiation Medicine Available to Cancer Patients

HANOI, Vietnam, May 8, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today thatVietnam's National Cancer Hospital, which is affiliated with the K Hospital, will soon begin treating cancer patients with advanced technology from Elekta. The K hospital has invested in a Leksell Gamma Knife® Icon...

2019-05-08 14:36 1314

Kazia calls for greater awareness of the most lethal women's disease in Australia

SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal women's disease in Australia. Every year, approximately 1,600 Australian women are...

2019-05-08 09:55 6345

Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints

SUZHOU, China, May 8, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company ("Lilly") jointly announced today that IBI301, a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody being co-developed as a potential bios...

2019-05-08 08:00 8046

Agfa Earns Acclaim from Frost & Sullivan for the Enhanced Diagnostic Capability and Flexibility of its Multi-purpose DR 800 System

SANTA CLARA, California, May 7, 2019 /PRNewswire/ -- Based on its recent analysis of the global multipurpose digital radiography (DR) systems market, Frost & Sullivan recognizesAgfa NV (Agfa) with the 2019 Global New Product Innovation Award for its DR 800 multi-purpose system. The product combin...

2019-05-07 20:07 1072

Half-year Figures: ZEISS Innovations Help Achieve Strong Growth

OBERKOCHEN, Germany, May 7, 2019 /PRNewswire/ -- The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 (ended31 March 2019) and saw its revenue rise by 9 percent to EUR 3.019 billion (1st six months of 2017/18:EUR 2.773 billion). At EUR 443 million, earnings before ...

2019-05-07 16:06 1654

Saudi Ministry of Health Makes Access to Health Services Easier With New Online Appointment App "MAWID"

RIYADH, Saudi Arabia, May 7, 2019 /PRNewswire/ -- Worldwide, e-Health is playing a significant role in driving healthcare evolution. According to the World Health Organization, healthcare costs globally are increasing by nearly 5% annually and health systems see e-Health as contributing significa...

2019-05-07 14:00 2231

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

YOKNEAM, Israel, May 7, 2019 /PRNewswire/ -- Rapid Medical , a company focused on the development of next generation neurovascular devices, today announced that its Comaneci device received FDA clearance as a Temporary Coil Embolization Assist Device. The Comaneci ...

2019-05-07 09:00 1447

Innovation Tour on Medical Design and Manufacturing; Medtec China 2019 Visitor Registration Initiated

SHANGHAI, May 7, 2019 /PRNewswire/ -- The 15th Exhibition of Medical Device Design & Manufacturing inChina (Medtec China 2019) will be held from September 25–27 inShanghai. As a leading international exhibition of medical device design and manufacturing inChina, Medtec China will gather 450+ exhi...

2019-05-07 09:00 2228

Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore

Launch of Activated Form of Critical Bacteria B. Infantis in Asia Fulfills Li Ka Shing Foundation's Vision, Caps First Quarter of Major Activity in the Continent DAVIS, California, May 7, 2019 /PRNewswire/ -- Evolve BioSystems, makers of  Evivo® baby probiotic, today announced that its flagship c...

2019-05-07 05:00 2033

Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100

PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certifi...

2019-05-06 21:00 1955

Bardy Diagnostics Earns Acclaim from Frost & Sullivan for Its Groundbreaking Carnation Ambulatory Monitor™ Patch for Arrhythmia Monitoring

CAM™'s unique P-wave-centric ECG monitor offers unmatched signal clarity and superior arrhythmia detection SANTA CLARA, California, May 6, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote cardiac monitoring market, Frost & Sullivan recognizesBardy Diagnostics, Inc. ...

2019-05-06 20:00 1251

Frost & Sullivan Publishes Annual Update on Cellect

TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...

2019-05-06 18:11 854

Frost & Sullivan Publishes Annual Update on Brainsway

TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...

2019-05-06 17:57 854

Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

TAICANG, China, May 6, 2019 /PRNewswire/ -- Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody, CBP-201. The randomized, double-blind, placebo-controlled study, conducted inMelbourne, Australia, evaluated t...

2019-05-06 17:00 877
1 ... 378379380381382